Viemed Healthcare, Inc. (VMD)

Market Cap	333.27M +26.7%
Revenue (ttm)	301.61M +25.2%
Net Income	14.50M +3.7%
EPS	0.36 +6.5%
Shares Out	38.09M
PE Ratio	24.27
Forward PE	17.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	178,384
Open	8.82
Previous Close	8.84
Day's Range	8.70 - 8.82
52-Week Range	6.05 - 12.61
Beta	1.09
Analysts	Hold
Price Target	12.50 (+42.86%)
Earnings Date	Nov 4, 2026

About VMD

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 1,438
• Stock Exchange: NASDAQ
• Ticker Symbol: VMD
• Website: https://www.viemed.com

Financial Performance

In 2025, Viemed Healthcare's revenue was $270.28 million, an increase of 20.52% compared to the previous year's $224.26 million. Earnings were $14.93 million, an increase of 32.57%.

Analyst Summary

According to 2 analysts, the average rating for VMD stock is "Hold." The 12-month stock price target is $12.5, which is an increase of 42.86% from the latest price.

Price Target

$12.5

(42.86% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 16, 2026

Data Sources Report a data error